Janssen

Johnson & Johnson Receives Two Cancer Drug Approvals

The US FDA approved Akeega and Talvey late last week. Phase 3 trials validated Akeega's use in the treatment of patients with BRCA-positive prostate cancer. Talvey is authorized for patients with heavily pretreated multiple myeloma.

News

Janssen Sciences Ireland is Overall Winner of ISPE’s 2021 Facility of the Year Awards

The International Society for Pharmaceutical Engineering (ISPE) has announced Janssen Sciences Ireland as the 2021 Facility of the Year Awards (FOYA) Overall Winner.

News • Innovation

Artificial Intelligence for New Drug Design

Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies.

News • Chemistry

Innovation and Creativity in the Pharmaceutical Industry

The International Society for Pharmaceutical Engineering (ISPE) announced the 2021 Facility of the Year Awards (FOYA) Category Winners—including two winners of Special Recognition Awards for Operational Agility: Covid-19 Impact.

Topics • Technology

Novozymes Biopharma Announces Collaboration with Janssen to Evaluate Proprietary Veltis Half-Life Extension Technology

News

EU Fines Drugmakers €16 million for Painkiller Delay

News

Drugmakers, Academics Pool R&D in $265 Million EU Project

News

Britain to Fund Prostate Cancer Pill in U-turn

News

US Senate Probes Painkiller Makers, Allied Groups

News

Johnson & Johnson Reaches Agreement On Risperdal Misdemeanor Charge

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

From Lab to Market Challenge

Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.